Advanced Adult Primary Liver Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced Adult Primary Liver Cancer trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT07018518

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

In this single-center,open-label, phase I study, the safety and efficacy of PIN in combination with programmed cell death protein antibody (anti-PD1) therapeuti…

China25 participantsStarted 2025-06-20

Treatment: PIN +anti-PD1

All recent trials (100 shown)

CompletedNot Applicable

NCT01899261

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

This pilot clinical trial studies stereotactic body radiation therapy in treating patients with liver cancer that cannot be removed by surgery. Stereotactic rad…

United States20 participantsStarted 2010-10-07

Treatment: Stereotactic Radiosurgery

Active — Not RecruitingPhase 2

NCT03680508

TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer

TSR-022 (cobolimab, TIM-3 binding antibody) and TSR-042 (dostarlimab, PD-1 binding antibody) may stop the growth of tumor cells by allowing the immune system to…

United States42 participantsStarted 2019-12-19

Treatment: TSR-022 and TSR-042

Advanced Adult Primary Liver Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

All recent trials (100 shown)

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

All recent trials (100 shown)

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Can…

Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or B…

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequ…

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer

Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery